Litecoin Could See ETFs Before Solana & XRP – As Sui and Remittix Tipped For Huge Gains In 2025
Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects growth to accelerate.
Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects growth to accelerate.
Pfizer Inc. shares fell 2% Tuesday despite the drugmaker topping Wall Street’s revenue and profit estimates in its fourth-quarter results.
